Sun-24-02-2019, 19:14 PM
(This post was last modified: Sun-24-02-2019, 19:19 PM by D Foster. Edited 1 time in total.)
(Sat-23-02-2019, 22:08 PM)Fred Wrote:(Sat-23-02-2019, 20:30 PM)JohnB Wrote: Mmmmm fascinating read. One thing is obvious these drug companies certainly know how to charge.
Interesting there is no mention of DMF derivatives.
Yes they do know how to charge, but you have to think of all the research and tests involved to make it conform today. Something like Methotrexate has been around a long time and is so cheap to make, but it doesn't have a good track record if we are honest for treating psoriasis.
No the French still think that DMF is not a treatment that should be included. I did ask about it once, but was told that it is very unlikely that DMF will ever be offered in France.
(Sat-23-02-2019, 20:35 PM)Imapsomom Wrote: Interesting stuff. Thanks Fred.
You are welcome, It is much longer than what I posted but it does give you the basics of how the French system works when it come to psoriasis. I am like the rest of you just a patient, but thought it would be interesting to show how the French health care system treats it's psoriasis patients.
Edit just seen Jim's post. Yes Methotrexate is cheap, but I stand by what I have always said "It should not be used to treat psoriasis, it is a poison that will only lead to people needing something else."
That's very interesting Fred ,I would have thought that the process would be very similar in the NHS ,MTX is cheap because it can be manufactured by any company and it's no more a poison than other treatments Fred and we all move on to something else anyway so that's not an argument at all. Some of these listed have severe psychiatric effects ,not a good side effect to have.